Home » Canada Outlines Process to Review Drugs for Needy Countries
Canada Outlines Process to Review Drugs for Needy Countries
January 15, 2007
New guidance issued Dec. 6 by Health Canada describes the process for applying to the Therapeutic Products Directorate (TPD) for a patented drug for export to least-developed and developing countries under Canada’s Access to Medicines Regime (CAMR).
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor